TechNavio's analysts forecast the Blood Glucose Monitoring Device market in
the US to grow at a CAGR of 3.8 percent over the period 2011-2011. One of the
key factors contributing to this market growth is the introduction of personal
testing kits. The Blood Glucose Monitoring Device market in the US has also
witnessed the adoption of continuous glucose monitoring systems. However, the
unwillingness of diabetes patients to use blood glucose monitoring devices
could pose a challenge to the growth of this market.
TechNavio's report, the Blood Glucose Monitoring Device Market in the US
2011-2015, has been prepared based on an in-depth analysis of the market with
inputs from industry experts. The report focuses on the US market; it also
covers the Blood Glucose Test Strips, Blood Glucose Meters, and Lancets market
landscape and its growth prospects in the coming years. The report also
includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Bayer Healthcare, LifeScan
Inc., Medtronic Inc., and Roche Diagnostics. Other vendors mentioned in the
report: Abbott Laboratories, Arkray Inc., Braun Melsungen AG, Dexcom, GlySens
Inc., Hainice Medical Inc., Nipro, Diagnostics Inc., Nova Biomedical, and
Terumo Corporation.
Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report.
Details provided within the report
Table of Contents
Table of Contents
01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
Key Offerings
04. Market Landscape
Market Size
Key Market Segments
04.1 Blood Glucose Test Strips Market in the US
04.2 Blood Glucose Meters Market in the US
04.3 Lancets Market in the US
Blood Glucose Monitoring Device Market in the US by Forecast of Key
Market Segmentation
Treatment Methods for Diabetic Patients
Major Complications due to Diabetes among the US Population
Five Forces Analysis
05. Rate of Incidence and Prevalence
06. Vendor Landscape
Product Portfolio Matrix
07. Buying Criteria
08. Market Growth Drivers
09. Drivers and their Impact
Impact of Drivers on End-user Category
10. Market Challenges
11. Impact of Drivers and Challenges
12. Market Trends
13. Key Vendor Analysis
13.1 LifeScan Inc.
Business Overview
SWOT Analysis
13.2 Roche Diagnostics
Business Overview
SWOT Analysis
13.3 Bayer Healthcare
Business Overview
SWOT Analysis
13.4 Medtronic Inc.
Business Overview
SWOT Analysis
13.5 Abbott Laboratories
Business Overview
SWOT Analysis
14. Other Reports in this Series
List of Exhibits:
Exhibit 1: Blood Glucose Monitoring Device Market in the US by Market
Segmentation
Exhibit 2: Blood Glucose Monitoring Device Market in the US 2011-2015 (US$
million)
Exhibit 3: Blood Glucose Monitoring Device Market in the US by Key Market
Segmentation 2011
Exhibit 4: Blood Glucose Test Strips Market in the US 2011-2015 (US$
million)
Exhibit 5: Blood Glucose Meters Market in the US 2011-2015 (US$ million)
Exhibit 6: Lancets Market in the US 2011-2015 (US$ million)
Exhibit 7: Blood Glucose Monitoring Device Market in the US by Forecast of
Key Market Segmentation 2011-2015 (US$ million)
Exhibit 8: Blood Glucose Monitoring Device Market in the US by Market
Forecast Segmentation (2011-2015)
Exhibit 9: Blood Glucose Monitoring Devices Market in the US by Treatment
Methods
Exhibit 10: Major Complications among Diabetic Population in the US
(percentage)
Exhibit 11: Blood Glucose Monitoring Device Market in the US by Vendor
Segmentation 2011
Blood Glucose Monitoring Market in the US 2011-2015 published by Infiniti Research Limited (Technavio) in July 5, 2012. This report consists of Pages: 46 and the price starts from US $ 1500.
